No Result

View All Result

No products in the cart.

2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑

Home StudyGraphics

#VisualAbstract 177Lu-PSMA-617 Prolonged Radiographic Progression-free Survival in Metastatic Prostate Cancer

byAngel GaoandAlisha Yi

October 8, 2024

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract 177Lu-PSMA-617 Prolonged Radiographic Progression-free Survival in Metastatic Prostate Cancer

Click here to read this study in the Lancet.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Borderline-low hemoglobin levels linked to increased mortality

Predicting adherence to gamified cognitive training using early phase game performance data

RelatedReports

A collection of symbolic items such as a microscope

Artificial Intelligence

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

September 30, 2026

Chronic Disease

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

September 22, 2026

Cardiology

Borderline-low hemoglobin levels linked to increased mortality

September 14, 2026

Radiation plus hormone therapy may improve prostate cancer survival

Chronic Disease

Enzalutamide (Xtandi) and abiraterone (Zytiga) may have similar effectiveness in metastatic castration-sensitive prostate cancer

July 22, 2026

Institute of Medicine identifies cost variation between geographic regions

Communities That HEAL intervention does not reduce opioid-related mortality

Axatilimab reduces symptoms in patients with graft versus host disease

Resection of colorectal liver metastases may improve cost and longevity

Liver transplantation plus chemotherapy improves survival in patients with unresectable colorectal liver metastases

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract 177Lu-PSMA-617 Prolonged Radiographic Progression-free Survival in Metastatic Prostate Cancer

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Borderline-low hemoglobin levels linked to increased mortality

Predicting adherence to gamified cognitive training using early phase game performance data

Communities That HEAL intervention does not reduce opioid-related mortality

RelatedReports

Artificial intelligence (AI) capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Borderline-low hemoglobin levels linked to increased mortality

Enzalutamide (Xtandi) and abiraterone (Zytiga) may have similar effectiveness in metastatic castration-sensitive prostate cancer

Communities That HEAL intervention does not reduce opioid-related mortality

Axatilimab reduces symptoms in patients with graft versus host disease

Liver transplantation plus chemotherapy improves survival in patients with unresectable colorectal liver metastases

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits